{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:17:35Z","timestamp":1762377455046},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,8]]},"DOI":"10.7759\/cureus.46683","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T07:40:51Z","timestamp":1696837251000},"source":"Crossref","is-referenced-by-count":3,"title":["Effects of Concurrent Dosing on the Efficacy of Tissue Plasminogen Activator and Deoxyribonuclease in the Treatment of Pleural Infection"],"prefix":"10.7759","author":[{"given":"Vikas","family":"Pathak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukash","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00217114","article-title":"Mortality among patients with pleural effusion undergoing thoracentesis","volume":"46","author":"DeBiasi EM","year":"2015","unstructured":"DeBiasi EM, Pisani MA, Murphy TE, Araujo K, Kookoolis A, Argento AC, Puchalski J. Mortality among patients with pleural effusion undergoing thoracentesis. Eur Respir J. 2015, 46:495-502. 10.1183\/09031936.00217114","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman NM","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, et al.. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011, 365:518-26. 10.1056\/NEJMoa1012740","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.01.037","article-title":"Predictive variables for failure in administration of intrapleural tissue plasminogen activator\/deoxyribonuclease in patients with complicated parapneumonic effusions\/empyema","volume":"154","author":"Khemasuwan D","year":"2018","unstructured":"Khemasuwan D, Sorensen J, Griffin DC. Predictive variables for failure in administration of intrapleural tissue plasminogen activator\/deoxyribonuclease in patients with complicated parapneumonic effusions\/empyema. Chest. 2018, 154:550-6. 10.1016\/j.chest.2018.01.037","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.09.038","article-title":"Management of pleural space infections: a population-based analysis","volume":"133","author":"Farjah F","year":"2007","unstructured":"Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007, 133:346-51. 10.1016\/j.jtcvs.2006.09.038","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.08.464","article-title":"Effects of concurrent dosing on the efficacy of tissue plasminogen activator and DNase in the treatment of pleural infection","volume":"154","author":"Zhou C","year":"2018","unstructured":"Zhou C, Pathak V. Effects of concurrent dosing on the efficacy of tissue plasminogen activator and DNase in the treatment of pleural infection. Chest. 2018, 154:510A. 10.1016\/j.chest.2018.08.464","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201407-329OC","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery","volume":"11","author":"Piccolo F","year":"2014","unstructured":"Piccolo F, Pitman N, Bhatnagar R, et al.. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Ann Am Thorac Soc. 2014, 11:1419-25. 10.1513\/AnnalsATS.201407-329OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.01.30","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection","volume":"7","author":"Piccolo F","year":"2015","unstructured":"Piccolo F, Popowicz N, Wong D, Lee YC. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection. J Thorac Dis. 2015, 7:999-1008. 10.3978\/j.issn.2072-1439.2015.01.30","journal-title":"J Thorac Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000443334","article-title":"Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease","volume":"91","author":"Mehta HJ","year":"2016","unstructured":"Mehta HJ, Biswas A, Penley AM, Cope J, Barnes M, Jantz MA. Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease. Respiration. 2016, 91:101-6. 10.1159\/000443334","journal-title":"Respiration"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201609-673OC","article-title":"Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project","volume":"14","author":"Popowicz N","year":"2017","unstructured":"Popowicz N, Bintcliffe O, De Fonseka D, et al.. Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project. Ann Am Thorac Soc. 2017, 14:929-36. 10.1513\/AnnalsATS.201609-673OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14261","article-title":"Alteplase dose assessment for pleural infection therapy (ADAPT) study-2: use of 2.5\u00a0mg alteplase as a starting intrapleural dose","volume":"27","author":"Popowicz N","year":"2022","unstructured":"Popowicz N, Ip H, Lau EPM, et al.. Alteplase dose assessment for pleural infection therapy (ADAPT) study-2: use of 2.5\u00a0mg alteplase as a starting intrapleural dose. Respirology. 2022, 27:510-6. 10.1111\/resp.14261","journal-title":"Respirology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201602-127OC","article-title":"Concurrent intrapleural instillation of tissue plasminogen activator and DNase for pleural infection. A single-center experience","volume":"13","author":"Majid A","year":"2016","unstructured":"Majid A, Kheir F, Folch A, et al.. Concurrent intrapleural instillation of tissue plasminogen activator and DNase for pleural infection. A single-center experience. Ann Am Thorac Soc. 2016, 13:1512-8. 10.1513\/AnnalsATS.201602-127OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/LBR.0000000000000461","article-title":"Concurrent versus sequential intrapleural instillation of tissue plasminogen activator and deoxyribonuclease for pleural infection","volume":"25","author":"Kheir F","year":"2018","unstructured":"Kheir F, Cheng G, Rivera E, et al.. Concurrent versus sequential intrapleural instillation of tissue plasminogen activator and deoxyribonuclease for pleural infection. J Bronchology Interv Pulmonol. 2018, 25:125-31. 10.1097\/LBR.0000000000000461","journal-title":"J Bronchology Interv Pulmonol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.8.855","article-title":"Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion","volume":"30","author":"Hamblin SE","year":"2010","unstructured":"Hamblin SE, Furmanek DL. Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion. Pharmacotherapy. 2010, 30:855-62. 10.1592\/phco.30.8.855","journal-title":"Pharmacotherapy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.08.039","article-title":"Optimal timing of thoracoscopic drainage and decortication for empyema","volume":"97","author":"Chung JH","year":"2014","unstructured":"Chung JH, Lee SH, Kim KT, Jung JS, Son HS, Sun K. Optimal timing of thoracoscopic drainage and decortication for empyema. Ann Thorac Surg. 2014, 97:224-9. 10.1016\/j.athoracsur.2013.08.039","journal-title":"Ann Thorac Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-21-1083","article-title":"Outcome of parapneumonic empyema managed surgically or by fibrinolysis: a multicenter study","volume":"13","author":"Federici S","year":"2021","unstructured":"Federici S, B\u00e9dat B, Hayau J, et al.. Outcome of parapneumonic empyema managed surgically or by fibrinolysis: a multicenter study. J Thorac Dis. 2021, 13:6381-9. 10.21037\/jtd-21-1083","journal-title":"J Thorac Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2020.11.005","article-title":"Cost-effectiveness analysis of fibrinolysis vs thoracoscopic decortication for early empyema","volume":"112","author":"Shipe ME","year":"2021","unstructured":"Shipe ME, Maiga AW, Deppen SA, et al.. Cost-effectiveness analysis of fibrinolysis vs thoracoscopic decortication for early empyema. Ann Thorac Surg. 2021, 112:1632-8. 10.1016\/j.athoracsur.2020.11.005","journal-title":"Ann Thorac Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/194965-effects-of-concurrent-dosing-on-the-efficacy-of-tissue-plasminogen-activator-and-deoxyribonuclease-in-the-treatment-of-pleural-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:06Z","timestamp":1707508446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/194965-effects-of-concurrent-dosing-on-the-efficacy-of-tissue-plasminogen-activator-and-deoxyribonuclease-in-the-treatment-of-pleural-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,8]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.46683","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,8]]}}}